Hyrimoz-crohns/uc Starter
Brand for: Adalimumab-adaz
My Prescription
Payment
Select pharmacy
$690.95
Print or send this coupon to your phone
WalgreensPowered byAbout Hyrimoz-crohns/uc Starter
Drug Details
Adalimumab is a medication designed to alleviate pain and swelling associated with various forms of arthritis, including rheumatoid, psoriatic, juvenile idiopathic, and ankylosing spondylitis. Additionally, it is effective in treating certain skin conditions like plaque psoriasis and hidradenitis suppurativa. The drug functions by inhibiting a protein in the immune system known as tumor necrosis factor (TNF), which contributes to joint swelling and damage, as well as the formation of red, scaly patches in psoriasis. As a TNF blocker, Adalimumab helps decrease joint inflammation, thereby reducing joint damage and preserving joint function. It is also used to manage specific bowel disorders such as Crohn's disease and ulcerative colitis, as well as an eye condition called uveitis. This information pertains to a range of Adalimumab products, including adalimumab, adalimumab-aacf, adalimumab-aaty, adalimumab-adaz, adalimumab-adbm, adalimumab-afzb, adalimumab-aqvh, adalimumab-atto, adalimumab-bwwd, adalimumab-fkjp, and adalimumab-ryvk.
Hyrimoz-crohns/uc Starter (Adalimumab-adaz) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 0.8ML of 80MG/0.8ML | 1 Pen | $1,365.39 | $1,365.39 |
| 0.8ML of 80MG/0.8ML | 2 Pens | $2,722.78 | $1,361.39 |
| 0.8ML of 80MG/0.8ML | 3 Pens | $4,080.17 | $1,360.06 |
Hyrimoz-crohns/uc Starter FAQs
Yes, Hyrimoz, which is a biosimilar to adalimumab, is used for the treatment of ulcerative colitis in adults. It helps reduce inflammation and manage symptoms associated with the condition.
The cost of Hyrimoz without insurance can vary significantly depending on the pharmacy and location. On average, the price can range from several thousand dollars per month. It is advisable to contact local pharmacies for specific pricing or explore patient assistance programs that may offer financial support.
Hyrimoz is a biosimilar to Humira, meaning it is designed to be highly similar in terms of safety, efficacy, and quality. Clinical studies have shown that Hyrimoz is as effective as Humira for the conditions it is approved to treat. However, individual responses can vary, and a healthcare provider should be consulted to determine the most appropriate treatment option.
Both Humira and Hyrimoz contain the active ingredient adalimumab and are used to treat similar conditions. Humira is the original brand, while Hyrimoz is a biosimilar. Biosimilars are designed to be highly similar to the original product with no clinically meaningful differences in terms of safety, purity, and potency.The choice between Humira and Hyrimoz may depend on factors such as cost, insurance coverage, and availability. It is important for patients to consult with their healthcare provider to determine which option is more suitable for their specific medical needs.
The cost of Hyrimoz can vary depending on factors such as the pharmacy, location, insurance coverage, and any available discounts or patient assistance programs. It is recommended to check with local pharmacies or consult with a healthcare provider or insurance company for the most accurate and up-to-date pricing information.